We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems,... read more Featured Products: More products

Download Mobile App




AI Platform Upgrades CT, Ultrasound, and Analytics Solutions

By HospiMedica International staff writers
Posted on 25 Dec 2017
Print article
Image: The Nvidia Quadro GPU will bring AI to medical imaging devices (Photo courtesy of GE Healthcare).
Image: The Nvidia Quadro GPU will bring AI to medical imaging devices (Photo courtesy of GE Healthcare).
GE Healthcare (GE, Little Chalfont, United Kingdom) and Nvidia (Santa Clara, CA, USA) have announced a series of imaging equipment advances to be powered by Nvidia’s artificial intelligence (AI) computing platform.

The collaboration between the two companies will accelerate a host deep learning solutions in order to design more sophisticated neural networks for healthcare and medical applications, ranging from real-time medical condition assessment, to point-of-care (POC) interventions, and even the use of predictive analytics for clinical decision-making. For patients, the partnership aims to drive lower radiation doses, speed up exam times, and provide a higher quality of medical imaging.

The first device to benefit from the collaboration is the Revolution Frontier computed tomography (CT) system, which processes images twice as fast as its predecessor by using Nvidia’s AI computing platform. The increased processing power is expected to deliver better clinical outcomes in liver lesion detection and kidney lesion characterization, potentially reducing the need for unnecessary follow-ups, benefiting patients with compromised renal function, and reducing non-interpretable scans with the assistance of Gemstone Spectral Imaging Metal Artefact Reduction (GSI MAR).

Another device that will benefit is the GE Healthcare Vivid E95 4D Ultrasound system, which will use the Nvidia graphics processing unit (GPU) to provide fast and accurate visualization and quantification of ultrasound imaging while streamlining workflows across the cSound imaging platform. The Nvidia Quadro GPU will accelerate reconstruction and visualization of blood flow and improve two-dimensional (2D) and four-dimensional (4D) imaging for echo lab and interventional deployments.

“Our partnership with GE Healthcare brings together great expertise in medical instruments and AI to create a new generation of intelligent instruments that can dramatically improve patient care,” said Jensen Huang, founder and CEO of NVIDIA.

“Healthcare is changing at remarkable speed, and the technologies that will transform the industry should reflect that pace,” said Kieran Murphy, President and CEO of GE Healthcare. “By partnering with NVIDIA, GE Healthcare will be able to deliver devices of the future – intelligent machines capable of empowering providers to improve the speed and accuracy of diagnoses for patients around the world.”

Modules of the new GE Healthcare Applied Intelligence analytics platform will also use Nvidia GPUs, the Nvidia CUDA parallel computing platform and application programming interface (API) model, and the NVIDIA GPU Cloud container registry to accelerate the creation, deployment, and consumption of deep learning algorithms in new healthcare analytic applications, which will be seamlessly integrated into various clinical and operational workflows.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Vital Signs Monitor
Aurus 10

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.